1 | cosmetic and chemical ingredients | | | | | | | 5 | 0.60% |
2 | 02 99 23 46 | | | | | | | 4 | 0.48% |
3 | a reconstructed model 3d | | | | | | | 4 | 0.48% |
4 | 33 02 99 23 | | | | | | | 4 | 0.48% |
5 | gingival irritation on a | | | | | | | 4 | 0.48% |
6 | of essential oils utilized | | | | | | | 3 | 0.36% |
7 | 99 23 46 46 | | | | | | | 3 | 0.36% |
8 | essential oils utilized in | | | | | | | 3 | 0.36% |
9 | on a reconstructed model | | | | | | | 3 | 0.36% |
10 | irritation on a reconstructed | | | | | | | 3 | 0.36% |
11 | oils utilized in cosmetic | | | | | | | 3 | 0.36% |
12 | in vitro assays in | | | | | | | 3 | 0.36% |
13 | way to evaluate the | | | | | | | 3 | 0.36% |
14 | and chemical ingredients food | | | | | | | 2 | 0.24% |
15 | oral products eg toothpaste | | | | | | | 2 | 0.24% |
16 | products eg toothpaste mouthwash | | | | | | | 2 | 0.24% |
17 | and exposure assessment to | | | | | | | 2 | 0.24% |
18 | of the cutaneous microbiome | | | | | | | 2 | 0.24% |
19 | eurosafeevaluation of the cutaneous | | | | | | | 2 | 0.24% |
20 | consumption and exposure assessment | | | | | | | 2 | 0.24% |
21 | pbpk methods consumer testing | | | | | | | 2 | 0.24% |
22 | eg toothpaste mouthwash gingival | | | | | | | 2 | 0.24% |
23 | methods consumer testing and | | | | | | | 2 | 0.24% |
24 | and pbpk methods consumer | | | | | | | 2 | 0.24% |
25 | toxicology and pbpk methods | | | | | | | 2 | 0.24% |
26 | computational toxicology and pbpk | | | | | | | 2 | 0.24% |
27 | reconstructed model 3d read | | | | | | | 2 | 0.24% |
28 | model 3d read more | | | | | | | 2 | 0.24% |
29 | with uptodate invitro assays | | | | | | | 2 | 0.24% |
30 | you with uptodate invitro | | | | | | | 2 | 0.24% |
31 | 3d gingival irritation on | | | | | | | 2 | 0.24% |
32 | at eurosafeevaluation of the | | | | | | | 2 | 0.24% |
33 | with a new security | | | | | | | 2 | 0.24% |
34 | screening for all your | | | | | | | 2 | 0.24% |
35 | is pleased to inform | | | | | | | 2 | 0.24% |
36 | reconstructed model 3d gingival | | | | | | | 2 | 0.24% |
37 | more direct and quantitative | | | | | | | 2 | 0.24% |
38 | direct and quantitative evaluation | | | | | | | 2 | 0.24% |
39 | and quantitative evaluation of | | | | | | | 2 | 0.24% |
40 | quantitative evaluation of the | | | | | | | 2 | 0.24% |